Tanaka W - Search Results

1

Ex vivo assays demonstrate potency and selectivity of the COX-2 inhibitor DFP after single dose administration.

Dallob A, De Lepeleire I, Van Hecken A, Porras A, Depré M, Mukhopadhyay S, Flynn M, Wildonger L, Gottesdiener K, Tanaka W, De Schepper P. Dallob A, et al. Among authors: tanaka w. Inflamm Res. 1999 Dec;48 Suppl 2:S130-1. doi: 10.1007/s000110050552. Inflamm Res. 1999. PMID: 10667849 Clinical Trial. No abstract available.

2

Biochemical activity, pharmacokinetics, and tolerability of MK-886, a leukotriene biosynthesis inhibitor, in humans.

Depre M, Friedman B, Tanaka W, Van Hecken A, Buntinx A, DeSchepper PJ. Depre M, et al. Among authors: tanaka w. Clin Pharmacol Ther. 1993 May;53(5):602-7. doi: 10.1038/clpt.1993.76. Clin Pharmacol Ther. 1993. PMID: 8387904 Clinical Trial.

3

Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers.

Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, Wynants K, Buntinx A, Arnout J, Wong PH, Ebel DL, Gertz BJ, De Schepper PJ. Van Hecken A, et al. Among authors: tanaka w. J Clin Pharmacol. 2000 Oct;40(10):1109-20. J Clin Pharmacol. 2000. PMID: 11028250 Clinical Trial.

4

The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.

Dallob AL, Sadick NS, Unger W, Lipert S, Geissler LA, Gregoire SL, Nguyen HH, Moore EC, Tanaka WK. Dallob AL, et al. Among authors: tanaka wk. J Clin Endocrinol Metab. 1994 Sep;79(3):703-6. doi: 10.1210/jcem.79.3.8077349. J Clin Endocrinol Metab. 1994. PMID: 8077349 Clinical Trial.

5

Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase-activating protein inhibitor.

Depré M, Friedman B, Van Hecken A, de Lepeleire I, Tanaka W, Dallob A, Shingo S, Porras A, Lin C, de Schepper PJ. Depré M, et al. Among authors: tanaka w. Clin Pharmacol Ther. 1994 Jul;56(1):22-30. doi: 10.1038/clpt.1994.96. Clin Pharmacol Ther. 1994. PMID: 8033491 Clinical Trial.

6

Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.

Herman GA, Bergman A, Stevens C, Kotey P, Yi B, Zhao P, Dietrich B, Golor G, Schrodter A, Keymeulen B, Lasseter KC, Kipnes MS, Snyder K, Hilliard D, Tanen M, Cilissen C, De Smet M, de Lepeleire I, Van Dyck K, Wang AQ, Zeng W, Davies MJ, Tanaka W, Holst JJ, Deacon CF, Gottesdiener KM, Wagner JA. Herman GA, et al. Among authors: tanaka w. J Clin Endocrinol Metab. 2006 Nov;91(11):4612-9. doi: 10.1210/jc.2006-1009. Epub 2006 Aug 15. J Clin Endocrinol Metab. 2006. PMID: 16912128 Clinical Trial.

7

MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.

Schwartz JI, Tanaka WK, Wang DZ, Ebel DL, Geissler LA, Dallob A, Hafkin B, Gertz BJ. Schwartz JI, et al. Among authors: tanaka wk. J Clin Endocrinol Metab. 1997 May;82(5):1373-7. doi: 10.1210/jcem.82.5.3912. J Clin Endocrinol Metab. 1997. PMID: 9141518 Clinical Trial.

8

Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin.

Schwartz JI, Musser BJ, Tanaka WK, Taggart WV, Mehta A, Gottesdiener KM, Greenberg HE. Schwartz JI, et al. Clin Pharmacol Drug Dev. 2015 Sep;4(5):337-45. doi: 10.1002/cpdd.194. Epub 2015 Jul 17. Clin Pharmacol Drug Dev. 2015. PMID: 27137142 Clinical Trial.

9

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses.

Herman GA, Stevens C, Van Dyck K, Bergman A, Yi B, De Smet M, Snyder K, Hilliard D, Tanen M, Tanaka W, Wang AQ, Zeng W, Musson D, Winchell G, Davies MJ, Ramael S, Gottesdiener KM, Wagner JA. Herman GA, et al. Among authors: tanaka w. Clin Pharmacol Ther. 2005 Dec;78(6):675-88. doi: 10.1016/j.clpt.2005.09.002. Clin Pharmacol Ther. 2005. PMID: 16338283 Clinical Trial.

10

Measurement of plasma angiotensin II: purification by cation-exchange chromatography.

Ledwith BJ, Cahill MK, Losse LS, Satiritz SM, Eydelloth RS, Dallob AL, Tanaka WK, Galloway SM, Nichols WW. Ledwith BJ, et al. Among authors: tanaka wk. Anal Biochem. 1993 Sep;213(2):349-55. doi: 10.1006/abio.1993.1431. Anal Biochem. 1993. PMID: 8238911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters